KR900701835A - Crf 유사체 - Google Patents

Crf 유사체

Info

Publication number
KR900701835A
KR900701835A KR1019900701135A KR900701135A KR900701835A KR 900701835 A KR900701835 A KR 900701835A KR 1019900701135 A KR1019900701135 A KR 1019900701135A KR 900701135 A KR900701135 A KR 900701135A KR 900701835 A KR900701835 A KR 900701835A
Authority
KR
South Korea
Prior art keywords
crf analog
crf
analog
Prior art date
Application number
KR1019900701135A
Other languages
English (en)
Other versions
KR0148264B1 (ko
Inventor
에도우어드 프레드릭 리비어 진
워커 베일 쥬니어 와일리
Original Assignee
더 솔크 인스티튜트 포오 바이오로지칼 스터디이즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 솔크 인스티튜트 포오 바이오로지칼 스터디이즈 filed Critical 더 솔크 인스티튜트 포오 바이오로지칼 스터디이즈
Publication of KR900701835A publication Critical patent/KR900701835A/ko
Application granted granted Critical
Publication of KR0148264B1 publication Critical patent/KR0148264B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019900701135A 1988-09-30 1989-09-28 Crf 유사체 KR0148264B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25167488A 1988-09-30 1988-09-30
US251,674 1988-09-30

Publications (2)

Publication Number Publication Date
KR900701835A true KR900701835A (ko) 1990-12-04
KR0148264B1 KR0148264B1 (ko) 1998-10-15

Family

ID=22952939

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701135A KR0148264B1 (ko) 1988-09-30 1989-09-28 Crf 유사체

Country Status (10)

Country Link
EP (1) EP0361954A3 (ko)
JP (1) JPH03501858A (ko)
KR (1) KR0148264B1 (ko)
AU (1) AU615805B2 (ko)
CA (1) CA1340964C (ko)
DK (1) DK130890D0 (ko)
IL (1) IL91663A0 (ko)
NZ (1) NZ230731A (ko)
WO (1) WO1990003393A1 (ko)
ZA (1) ZA897150B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
EP0521963B1 (en) * 1990-03-23 1998-08-12 The Salk Institute For Biological Studies Crf analogs
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
EP0781140A4 (en) * 1994-09-12 1999-11-03 Univ Pennsylvania FACTOR INHIBITING THE CORTICOTROPIN RELEASE AND METHOD FOR ITS USE
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792033A (en) * 1969-05-06 1974-02-12 Ciba Geigy Corp Acth-type hormones whose first aminoacid is of d-configuration
BR6915265D0 (pt) * 1969-06-10 1973-04-19 Ciba Geigy Processo para a preparacao de novos peptidios com atividade-acth
US4415558A (en) * 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
US4489163A (en) * 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
EP0153845B1 (en) * 1984-02-23 1993-04-21 The Salk Institute For Biological Studies Crf analogs

Also Published As

Publication number Publication date
DK130890A (da) 1990-05-28
EP0361954A3 (en) 1991-12-04
JPH03501858A (ja) 1991-04-25
KR0148264B1 (ko) 1998-10-15
NZ230731A (en) 1991-12-23
IL91663A0 (en) 1990-04-29
CA1340964C (en) 2000-04-18
DK130890D0 (da) 1990-05-28
AU615805B2 (en) 1991-10-10
AU4339889A (en) 1990-04-18
WO1990003393A1 (en) 1990-04-05
ZA897150B (en) 1990-06-27
EP0361954A2 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
ES2012750A4 (es) Conjunto recipiente-aplicador
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK188690D0 (da) Neutrocyt-aktiverende peptid-2
DK184489D0 (da) Bicyclodioner
DK201989A (da) Anaestesifordamper
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
DK113291D0 (da) Homogent enzymimmunassay
KR900701835A (ko) Crf 유사체
BR8906898A (pt) Jamela
DK137889D0 (da) Foldeaeske
DK182290A (da) Foldeaeske
DK165575C (da) Loeftesele
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
NO169999C (no) Langrennsski
DD277186A3 (de) Waelzlagerseparator
BR6800600U (pt) Hidro-serra
BR8805477A (pt) Milran transpantaneiro
BR8806232A (pt) Bau-casa
BR8806404A (pt) Multiregua
BR8804416A (pt) Papa-mosca
BR8803641A (pt) Tele-loto

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120507

Year of fee payment: 15

EXPY Expiration of term